☆ 4.5 Article

Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B

HEPATOLOGY RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase

Daniel Q. Huang et al.

Summary: This study found that a significant proportion of patients with chronic hepatitis B are in the indeterminate phase. Of these patients, around half remain indeterminate and one-fifth transition to the immune active phase. The risk of hepatocellular carcinoma is significantly higher in persistently indeterminate CHB patients, particularly in those aged 45 years and older.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B

Kazuharu Suzuki et al.

Summary: Switching from TDF to TAF for long-term treatment of hepatitis B virus can prevent renal dysfunction and bone loss, but its precise effects on blood lipid profile are still unclear. This study found that switching to TAF resulted in significantly increased levels of total cholesterol, high-density lipoprotein cholesterol, and oxidized low-density lipoprotein cholesterol, and an increase in the rate of dyslipidemia.

PLOS ONE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment

Sakura Kirino et al.

Summary: In chronic hepatitis B patients, the PAGE-B score can be used for HCC risk assessment, especially at different time points during NA treatment. The predictive ability of mPAGE-B and REACH-B at 2 years after NA treatment is not as good as PAGE-B.

JOURNAL OF VIRAL HEPATITIS (2021)

添加到收藏夹

Review Medical Laboratory Technology

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases

Nobuharu Tamaki et al.

Summary: M2BPGi, a novel serum marker for liver fibrosis, not only predicts liver fibrosis but also hepatocellular carcinoma development in various chronic liver diseases. Its levels vary depending on etiology and treatment, necessitating adjustment of the threshold for diagnosing liver fibrosis and predicting HCC based on background and treatment status.

ANNALS OF LABORATORY MEDICINE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice

Hidenori Toyoda et al.

Summary: Following the switch to TAF, patients with chronic hepatitis B showed continued improvement in virologic response and ALT normalization, with no significant changes in estimated glomerular filtration rate. Patients with chronic kidney disease at baseline also showed improvement in kidney function after switching to TAF.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma

Daniel Q. Huang et al.

Summary: This study compared Asian and non-Asian patients with HBV-related HCC and found that non-Asian patients were more likely to have HIV or hepatitis C co-infection, cirrhosis, decompensated liver disease, and advanced BCLC stage. However, non-Asian patients without cirrhosis had lower 5-year survival compared to Asians, and non-Asian ethnicity was independently associated with twice the risk of mortality in patients without cirrhosis.

LIVER INTERNATIONAL (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

Katsutoshi Tokushige et al.

Summary: NAFLD and NASH have become significant public health issues in both Western countries and Japan, with hepatic fibrosis being a key prognostic factor. Effective screening methods for NAFLD and urgent surveillance for HCC are necessary in Japan, where non-viral liver disease-related HCC cases are on the rise. Cardiovascular disease is the leading cause of death in NAFLD patients, emphasizing the importance of CVD monitoring in clinical practice. Several drug trials are ongoing for NAFLD/NASH therapy, with new treatments like SGLT2 inhibitors and GLP-1 analogues showing promise for future interventions.

HEPATOLOGY RESEARCH (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog

Sakura Kirino et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

George V. Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Virology

Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B

Nobuharu Tamaki et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma

Mi Young Jeon et al.

JOURNAL OF VIRAL HEPATITIS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy

Seung Up Kim et al.

JOURNAL OF VIRAL HEPATITIS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients

Lung-Yi Mak et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

Shun Kaneko et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update

Norihiro Kokudo et al.

HEPATOLOGY RESEARCH (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Comparison of hepatitis B virus genotypes B and C among chronically hepatitis B virus-infected patients who received nucleos(t)ide analogs: A multicenter retrospective study

Jun Inoue et al.

HEPATOLOGY RESEARCH (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis

Kazuharu Suzuki et al.

HEPATOLOGY RESEARCH (2019)

添加到收藏夹

Article Virology

Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B

Satoru . Hagiwara et al.

JOURNAL OF MEDICAL VIROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers

Toshifumi Tada et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues

B. Wang et al.

JOURNAL OF VIRAL HEPATITIS (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy

Ji Hyun Kim et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

Yao-Chun Hsu et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

JOURNAL OF HEPATOLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

JSH Guidelines for the Management of Hepatitis B Virus Infection

Yasuhiro Asahina et al.

HEPATOLOGY RESEARCH (2014)

添加到收藏夹

Article Biophysics

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

Y. Kanda

BONE MARROW TRANSPLANTATION (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis

Takashi Kumada et al.

JOURNAL OF HEPATOLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease

Yun-Fan Liaw et al.

HEPATOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus

Josephine Simonetti et al.

HEPATOLOGY (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

Ting-Tsung Chang et al.

HEPATOLOGY (2010)

添加到收藏夹

Review Gastroenterology & Hepatology

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

George V. Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy

Daniel J. Tenney et al.

HEPATOLOGY (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

The Natural History of Chronic Hepatitis B Virus Infection

Brian J. McMahon

HEPATOLOGY (2009)

添加到收藏夹

Review Gastroenterology & Hepatology

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

Giovanna Fattovich et al.

JOURNAL OF HEPATOLOGY (2008)

添加到收藏夹

Article Virology

Clinical significance of the genotype and core promoter/pre-core mutations in hepatitis B virus carriers

S Hagiwara et al.

INTERVIROLOGY (2006)

添加到收藏夹

Article Gastroenterology & Hepatology

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C

F Sugauchi et al.

GASTROENTEROLOGY (2003)

添加到收藏夹

Article Virology

Classifying hepatitis B virus genotypes

Y Miyakawa et al.

INTERVIROLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.